bio2018-mybio-sessionicon-session
Description

Enjoy our three panels on the French attractiveness in the field of Biotech. Please see the listed panels below.

1 - Artificial Intelligence in Healthcare, how to find the perfect balance between efficiency & ethics?
When: From 8:30 am to 10:15 am
Where: At Westin Boston Waterfront Hotel - Marina Ballroom IV - 425 Summer Street - Boston 02210
Registration and details at: https://www.eventbrite.com/e/artificial-intelligence-in-healthcare-how-to-find-the-perfect-balance-between-efficiency-ethics-tickets-45880940127

On the occasion of BIO 2018, Business France give you the opportunity to discuss about the impact of Artificial Intelligence in Healthcare and all the questions it raises. How does it work ? and what is under this word ?
For several years, AI has impacted the healthcare economy, the process of drug development and the management of diseases for patients. This new approach raise many questions in term of ethics and use of patients data to improve and accelerate drug development and public health policies.
France has made Artificial Intelligence a priority to, and we are pride to have this open discussion with our experts :
- Stéphane Verguet, Professor of Global Health at Harvard University, USA
- Dr. Monica Lopez, Executive Director, La Petite Noiseuse Productions, USA
-Erik Thompsen, CTO at Blender Logic, USA
-Daniel Serfaty, Chairman and CEO at Actima, USA
Alexis Normand, Head of business at Withings, a french company developping connected devices will moderate the panel
In case of any question you could have, please contact Alexandre Blanchot at alexandre.blanchot@businessfrance.fr

2 - France, an Economic Hub for Biotechnology in Europe
This conference is organized in collaboration with France Biotech
When: From 10:30 am to 11:45 am
Where: At Westin Boston Waterfront Hotel - Marina Ballroom IV - 425 Summer Street - Boston 02210
Registration and details at: https://www.eventbrite.com/e/france-an-economic-hub-in-europe-for-biotechnology-tickets-46072902291

Speakers: John Brennan, Secretary General at EuropaBio; Eric Forest, Chairman and CEO of Enternext at Euronext; Thomas Delano, Principal at BCG - Healthcare; and Isabelle Marguet, Partner specialized in M&A at Cabinet Dechert

3 - Emerging diseases : Pasteur’s legacy under the spotlight of Climate Change

This conference is organized in collaboration with the Consulate General of France in Boston and the Office for Science and Technology from the French Embassy in the US.
When: From 12:00 pm to 1:00 pm
Where: At Westin Boston Waterfront Hotel - Marina Ballroom IV - 425 Summer Street - Boston 02210
Registration and details at: https://www.eventbrite.com/e/emerging-diseases-pasteurs-legacy-under-the-limelight-of-climate-change-tickets-46158736022

Speakers: Stéphane Bancel, CEO of Moderna Therapeutics; Gary J. Nabel, Chief Scientific Officer and Senior Vice President at Sanofi; Branka Horvath, Head of the Viral Infection Immunobiology team in Lyon; Ronald B. Corley, Director of the New emerging infectious disease laboratory at Boston University; and Benoît Gamain, Head of the Malaria Pathogenesis team in Paris, France



Tags